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Letters
Diabetic retinopathy: time
for action. No complacency
please!
Editor – The importance of diabetic
retinopathy as a cause of blindness has
increased because of longevity and
decline in the other preventable causes of
blindness in developing countries (1).
A diabetic can have a serious eye disease
and not even know it until irreversible
vision loss has occurred. It is estimated
that by the year 2010 the world diabetic
population will have doubled, reaching
an estimated 221 million (2). The timely
diagnosis and referral for management
of diabetic retinopathy can prevent 98%
of severe visual loss (3). Early diagnosis
and treatment of diabetic retinopathy
in Sweden has resulted in the virtual
elimination of blindness due to diabetic
retinopathy (4). An estimated 2–5% of
diabetics have proliferative diabetic
retinopathy (5) which, if not treated,
causes blindness in more than 50% (6).
Therefore it would be correct to state that
the underlying cause of blindness in the
majority of diabetic patients is not
diabetic retinopathy but the misdiagnosis
of diabetic retinopathy. To achieve near
universal coverage, the screening meth-
od should be community-based and
the point of delivery within easy reach
of the population.
Currently, yearly dilated direct
ophthalmoscopic examination seems
the best approach but the number of
ophthalmologists available is the limiting
factor in initiating an ophthalmologist-
based screening service inmost countries.
Because of this, screening will have to be
organized in an ‘‘ophthalmologist-led’’
system rather than an ‘‘ophthalmologist-
based’’ one in most communities. It is
a sad state of affairs that a strategy which
is cost-effective and has proved its
worth (4) is not being implemented by
many countries. Despite the fact that
most diabetic patients attend some
sort of health facility, their eye disease
remains undetected because it is not
looked for until the patient is sympto-
matic. Clearly, a ‘‘team’’ approach to
screening, detecting, managing and
monitoring the complex facets of this
disease will serve the best interests of the
patient. The present need is to make
screening for diabetic retinopathy man-
datory by all sufficiently trained health
care providers, at least for all diabetic
patients attending any sort of health care
clinic. We must respond now, not
with excuses but with action. n
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Societal variables are central
to effective HIV intervention
models
Editor – Nagelkerke et al. (1) model
the impact of interventions to prevent
HIV transmission in India andBotswana
to provide evidence for policy-making.
Behavioural interventions focused
on sex workers, treatment of sexually
transmitted infections, mother-to-child
transmission, and highly active antire-
troviral therapy (HAART) for female
sex workers and the entire infected
population. In this model, HAART
targeted at sex workers would have
limited sustained effectiveness among
sex workers in contrast to behavioural
interventions which would drive the
epidemic to extinction in India.
While Nagelkerke et al. outline
many assumptions underpinning their
model, they do not acknowledge the
heterogeneity of the HIV epidemic
across India. India has multiple HIV
epidemics which are driven by distinct
patterns of risk and vulnerability (2)
and these are, in turn, driven by diverse
social and economic factors. It is the
disparity in these societal variables which
renders assumptions about the extent
of risk and the effectiveness of any
intervention across the country
problematic.
Whilst modelling can aid in priority-
setting, the authors must rely on
assumptions and simplified characteriza-
tions of complex realities which carry
significant ramifications for the validity
of the results and HIV prevention policy
in general. For example, such assump-
tions include the targeting of sex workers
in sites where condom promotion and
distribution may be feasible. Some
interventions with brothel-based sex
workers in India have achieved remark-
able success in reducing risk behaviours
(3). In many areas of India, however,
sex workers operate from home or on the
streets and are less easily reached by
public health interventions – including
condom promotion or HAART. Sex
work remains illegal in India and police
may consider possession of condoms
by women as evidence of sex work.
Similarly, interventions using HAART
require a functioning health care system.
In India, over 75% of outpatient care is
in the private sector, much of which is
described as ‘‘low quality’’ and provided
by ‘‘untrained practitioners’’ (4).
There is increasing recognition of
the importance of addressing societal
factors to curb the HIV epidemic (5).
Over (6) has suggested that eight societal
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variables explain more than half of the
differences in urban HIV prevalence
between countries. Understanding
societal variables (such as caste, gender
relations, power in sexual relationships,
etc.) may help in determining the future
spread of the epidemic and contribute
to explaining the local effectiveness of
public health interventions – such as
programmes to reduce risk for sex
workers.
In addition to targeted behaviour
change interventions, the HIV epidemic
in India may be contained through a
multisectoral approach that takes into
account the highly diverse nature of
behavioural, social and economic risk
and vulnerability. Improved under-
standing of the contribution of societal
variables is necessary in order to produce
models that reflect the impact of
addressing these variables on overall
HIV incidence in India. n
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Global response to
antimicrobial resistance
Editor – In a recent issue of the Bulletin,
Smith & Coast (1) succinctly reviewed
the emerging global scourge of anti-
microbial resistance (AMR). Neverthe-
less, their strategies for containment
of the emergence and dissemination
of AMR in Table 1 do not include an
evaluation of the potency and bio-
availability of antibiotics, probiotics
or vaccines being offered to the public
worldwide. Plausible host factors or
pharmacokinetics of drugs have also
been ignored.
Antimicrobial agents require con-
stant storage within a controlled
temperature range: from either subzero
to 2–8 oC, or 15 to 25–30 oC (2).
Inadvertent exposure to extremes of
temperature or humidity would alter
their potency. This was evident during
a Nigerian field trial when the active
ingredients in 48% of the samples of
common medicines were found to be
outside the limits specified by the British
Pharmacopoeia (3). Identical scenarios
may occur with antimicrobial formula-
tions elsewhere. Such formulations
would be ineffective against microbial
replication and, being lower than the
required antibiotic quantum, encourage
selection and dissemination of resistant
microbes.
Obviously, any response at local,
national, regional or global levels to
manageAMRwill not be effective unless
losses in potency and bioavailability
of antimicrobial agents are monitored
regularly, including during their admin-
istration. Simple assay formats that
could accomplish qualitative and quan-
titative analysis of antimicrobial agents
in the clinical and household setting
should be standardized. Recently, Green
et al. (4) proposed a quick and simple
field test requiring few chemicals and
no sophisticated equipment to identify
artesenuate, an antimalarial drug. Iden-
tical tests for frequently used anti-
microbial agents would confirm
the quality of the antibiotics or probio-
tics being consumed.
The addition of chemical stabilizers
may well help retain the potency of
antibiotics and probiotics in adverse
environments. The least stable of the
common childhood vaccines, oral
polio vaccine is stabilized by the
addition of pirodavir and deuterium
oxide (5). Pre-stabilization of therapeu-
tics would not only prevent emergence
and dissemination of AMR, but be cost-
effective.
Host-induced factors could alter
the efficacy of therapeutic agents
offered against microbial infection. For
example, any concurrent formulations
of antacid containing magnesium
hydroxide or aluminium hydroxide alter
the efficacy of orally administered
therapeutic agents. The bioavalibility of
ciprofloxacin would be reduced drasti-
cally with a concurrent administration
of milk (6). Such eventualities cannot be
ignored and should be eliminated by
assaying the maximum drug plasma
concentration, including the area under
the assay curve. Undoubtedly, simpler
tests to measure drug concentration
in saliva or urine, rather than in blood,
could be employed. These tests would
be important assets for the global effort
to tackle AMR (1). n
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